Banc de Sang i Teixits published a new study in Advanced Science presenting a novel pharmacologically controlled STAb-T cell immunotherapy strategy.

The Banc de Sang i Teixits (Blood and Tissue Bank, BST) is a Catalan public company whose purpose is to transform and improve the life of many patients by providing an adequate and efficient supply of blood, blood products and tissues. This is made possible by more than 900 professionals from a wide range of fields. We are much more than a blood bank. We are a life bank, because our mission is to ensure that everyone who needs red blood cells, plasma, platelets, tissue or breast milk has it when and where it is needed. We provide health and well-being for more than 100,000 people a year. And we do it also thanks to research, the other main function of this life bank. We are leaders in the development of blood-, cell-, gene- and tissue-based therapies. We develop drugs with all these components, which are part of life and the springboard for progress in the new personalised medicine, the path of the future that is opening up new possibilities for curing many patients